Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Epoxidation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1066658A details efficient asymmetric synthesis of antiviral furanoside intermediates, offering scalable routes for HIV therapeutic manufacturing.
Patent CN1056612C details novel Salen-Mn catalysts and isoquinoline N-oxide ligands for enantioselective epoxidation, offering cost reduction in pharmaceutical intermediate manufacturing.
Novel epoxidation route for Voglibose intermediates. Reduces steps, eliminates protection groups, ensures high purity for diabetes drug manufacturing.
Patent CN109053637A reveals high-yield chiral synthesis. Reduces cost and improves supply chain reliability for agrochemical manufacturers.
Patent CN108299342B details a cost-effective synthesis of (2S,3R)-2,3-epoxy-1-tetradecanol using nickel boride catalysis, offering significant supply chain advantages.
Novel epoxidation-ring opening route for antiviral intermediates. Reduces cost and improves purity compared to lithium aluminum hydride methods. Reliable supplier.
Patent CN109053637B details a high-yield route for chiral epoxy intermediates. Offers cost-effective scale-up for pest control manufacturers.
Patent CN1298711C reveals a novel route for antifungal intermediates, eliminating protection steps for significant cost reduction and supply chain reliability.
Novel nickel-catalyzed route for (3Z,6Z,9S,10R)-9,10-epoxy-3,6-heneicosadiene offers scalable agrochemical manufacturing solutions.
Patent CN102321050A reveals a 6-step synthesis for Gypsy Moth Sex Pheromone with >98% ee. Discover cost-effective manufacturing and scalable supply solutions.
Advanced Sharpless epoxidation process for (S)-beta-hydroxy-gamma-butyrolactone. Delivers high enantiomeric excess and cost-effective supply chain solutions for pharmaceutical manufacturing.
Patent CN113666915B reveals a novel 5-step route for posaconazole intermediates using chiral iron catalysis, offering high purity and scalable manufacturing for global supply chains.
Patent CN102249976B discloses a scalable route to (-)-clausenamide using fructose-derived catalysts, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN110564755B details a novel enzymatic route for (S)-3-phenyl-1,2-epoxypropane. Discover cost-effective, metal-free manufacturing solutions for high-purity API precursors.
Patent CN111892559B details a high-yield asymmetric epoxidation of chalcones using chiral TADDOL ligands and rare earth metal amides, offering significant cost reduction in chiral epoxide manufacturing.
Patent CN107531662A reveals a scalable Nebivolol synthesis route avoiding chromatography. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN105017181A reveals a cost-effective route for Carfilzomib intermediates. Discover high-purity manufacturing solutions and supply chain advantages for proteasome inhibitors.
Patent CN102337307A reveals a green biocatalytic route for high-purity phenyl glycidol intermediates. Eliminate metal residues and reduce costs with scalable enzymatic epoxidation technology.
Novel patent CN115677771A offers efficient fosfomycin intermediate production with reduced costs and high purity for reliable pharmaceutical supply chains.
Patent CN114539077B reveals a novel asymmetric epoxidation route for levosalbutamol hydrochloride. Achieve high purity and scalable supply chain reliability.